Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Collegium Pharmaceutical (COLL) Leases (2019 - 2025)

Collegium Pharmaceutical has reported Leases over the past 7 years, most recently at $4.2 million for Q4 2025.

  • Quarterly results put Leases at $4.2 million for Q4 2025, down 28.08% from a year ago — trailing twelve months through Dec 2025 was $4.2 million (down 28.08% YoY), and the annual figure for FY2025 was $4.2 million, down 28.08%.
  • Leases for Q4 2025 was $4.2 million at Collegium Pharmaceutical, down from $4.4 million in the prior quarter.
  • Over the last five years, Leases for COLL hit a ceiling of $8.2 million in Q1 2021 and a floor of $4.2 million in Q4 2025.
  • Median Leases over the past 5 years was $6.3 million (2023), compared with a mean of $6.4 million.
  • Biggest five-year swings in Leases: fell 1.19% in 2024 and later fell 28.16% in 2025.
  • Collegium Pharmaceutical's Leases stood at $7.6 million in 2021, then decreased by 10.24% to $6.9 million in 2022, then fell by 12.13% to $6.0 million in 2023, then fell by 3.43% to $5.8 million in 2024, then fell by 28.08% to $4.2 million in 2025.
  • The last three reported values for Leases were $4.2 million (Q4 2025), $4.4 million (Q3 2025), and $5.3 million (Q2 2025) per Business Quant data.